0001225208-12-022233.txt : 20121102
0001225208-12-022233.hdr.sgml : 20121102
20121102141215
ACCESSION NUMBER: 0001225208-12-022233
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121101
FILED AS OF DATE: 20121102
DATE AS OF CHANGE: 20121102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reininger Cornelia
CENTRAL INDEX KEY: 0001559878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 121176243
MAIL ADDRESS:
STREET 1: 425 METRO PLACE NORTH SUITE 425
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 425 METRO PLACE NORTH
STREET 2: SUITE 300
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 425 METRO PLACE NORTH
STREET 2: SUITE 300
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
doc4.xml
X0306
4
2012-11-01
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001559878
Reininger Cornelia
425 METRO PLACE NORTH
SUITE 450
DUBLIN
OH
43017
1
SVP & Chief Medical Officer
Stock Option (Right to Buy)
2.8500
2012-11-01
4
A
0
88000.0000
0.0000
A
2022-11-01
Common Stock
88000.0000
88000.0000
D
Option vests 25% per year beginning on the first anniversary of the date of grant.
William J. Kelly, Jr., Attorney-In-Fact
2012-11-02